Organization

BRIGHTVIEW, LLC

According to 2025 Medicare claims, BRIGHTVIEW, LLC (NPI: 1659769446) practices opioid treatment program in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is BRIGHTVIEW, LLC (NPI: 1659769446; TIN: 472519577) and primary practice location at 45206-2348.

The organization's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 723 traditional Medicare patients, billed 16,238 HCPCS/CPT codes, and received $2,328,024 in Medicare payments. The top billing code was G2068 (Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opi). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $167,828 to $2,328,024. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.3M2018 Medicare payment: $167,828 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $346,357 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $920,553 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,696,987 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,952,087 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,310,676 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,328,024 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181041,569$167,828
20192383,470$346,357
20203697,007$920,553
202166012,298$1,696,987
202279114,685$1,952,087
202375716,460$2,310,676
202472316,238$2,328,024

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

No connected Part D records

No connected Part D records

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G2068Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opi3133,177$269
G0483Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms227777$241
G2077Periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for3433,524$116
G2079Take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure2284,249$70
80307Testing for presence of drug, by chemistry analyzers4102,213$61

Top 5 Part D drugs in 2024

By total drug costs.

No connected Part D drug-level records for 2024.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for BRIGHTVIEW, LLC?

Tedicare shows public-source Medicare data for BRIGHTVIEW, LLC (NPI 1659769446), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does BRIGHTVIEW, LLC have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to BRIGHTVIEW, LLC?

BRIGHTVIEW, LLC is linked to BRIGHTVIEW, LLC (billing NPI 1659769446) in the available physician profile data.

Does BRIGHTVIEW, LLC have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.